Lantheus Medical Imaging
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Lantheus Medical Imaging sits in the top decile of US sponsors by registered trial count (#696 of 15,742 sponsors by registered trial count).
Lantheus Medical Imaging: 22 sponsored US clinical trials, 2 recruiting.
Lantheus Medical Imaging sponsors 22 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 19 completed. 12 of these trials are in Phase 3-4 (later-stage) and 8 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Relapsed / Refractory Osteosarcoma, with 1 trials.
Top-decile sponsor footprint
Lantheus Medical Imaging ranks in the top decile of sponsors by registered trial count (#696 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
19 of 19 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
22 total, page 1 of 1
Lu-TARGO (177Lu-TARGeted Osteosarcoma Therapy)
NCT07357519
64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
NCT06298916
PYLARIFY® PET/CT or PET/MRI in Men With Favorable Intermediate Risk (FIR) Prostate Cancer
NCT06074510
DEF-315 Better Accuracy in Ejection Fraction (EF) Assessment With DEFINITY
NCT03719612
DEF-314 Better Accuracy in Ejection Fraction (EF) Assessment With DEFINITY
NCT03571672
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
NCT01347710
Prospective Evaluation of the Incidence of NSF in Patients With Kidney Disease Undergoing MR
NCT01135316
A Phase 1 Trial to Determine Dosimetry, Biodistribution and Safety of LMI 1195-101 in Healthy Subjects and Patients With Heart Failure
NCT00891241
A Study of Commercial DEFINITY® to Monitor the Effects of the Heart's Pulmonary Artery Pressure
NCT00918866
Study of [3H] BMS747158 in Healthy Male Subjects
NCT00930631
Development of 1-Day Rest/Stress Cardiac PET Perfusion Imaging Protocol of BMS747158
NCT00849108
Retrospective Safety Study to Compare Mortality in Intensive Care Unite (ICU) Patients Undergoing Echocardiography With or Without DEFINITY®
NCT01299649
A Phase I Study in Healthy Volunteers to Assess Dosimetry and Safety Following Injection of BMS747158 at Stress
NCT00707538
A Prospective, Phase IV, Surveillance Registry Study to Evaluate the Safety of DEFINITY® in Clinical Practice
NCT00625365
A Phase I Study in Healthy Volunteers to Assess Safety of BMS747158
NCT00707499
DMP115 in Patients With an Ejection Fraction Between 25%-40% to Evaluate the Use of Contrast Echocardiography to Assess Heart Function
NCT00401687
A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki Disease
NCT00162032
CARDIOLITE-413: A Study for Patients Who Had a PCI for an Acute MI
NCT00162331
A Trial to Determine Radiation Exposure to Organs and Assess the Safety of CARDIOLITE® in Pediatric Subjects
NCT00162045
A Study of Stress Echocardiography in Post-Menopausal Women at Risk for Coronary Disease
NCT00162370
Post-PCI:Cardiac Imaging in Patients With Diabetes to Detect Coronary Artery Blockages Previously Opened by Angioplasty
NCT00162357
A Study of Stress Heart Imaging in Patients With Diabetes at Risk for Coronary Disease.
NCT00162344
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 7 |
| Phase 2 | 1 |
| Phase 3 | 4 |
| Phase 4 | 8 |
Therapeutic Areas
What is open in the Lantheus Medical Imaging pipeline
2 recruiting of 22 indexed (9% open); 19 completed (86%).
Phase mix: 12 late (III/IV) vs 8 early (I/II) (balanced across stages).
Top condition: Relapsed / Refractory Osteosarcoma (1 trial), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Lantheus Medical Imaging: open-pipeline peers nationwide
Peers matched on 22 registered trials and 9% open enrollment, not the therapeutic-area sidebar.
Lantheus Medical Imaging sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 22 trials (± recruiting share)
- Alaunos Therapeutics · 22 trials · 0% recruiting
- Alexza Pharmaceuticals · 22 trials · 0% recruiting
- Calithera Biosciences · 22 trials · 0% recruiting
- Fate Therapeutics · 22 trials · 14% recruiting
Sponsors near 9% open enrollment (± trial volume)
- Alkermes · 9% recruiting · 66 trials
- DBV Technologies · 9% recruiting · 11 trials
- Florida Gulf Coast University · 9% recruiting · 11 trials
- Genfit · 9% recruiting · 11 trials
Related
What to do with this Lantheus Medical Imaging page
22 registered trials is a research-attention snapshot, not an endorsement of Lantheus Medical Imaging or any single study.
- 2 of Lantheus Medical Imaging's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Relapsed / Refractory Osteosarcoma is the condition Lantheus Medical Imaging studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Relapsed / Refractory Osteosarcoma trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Lantheus Medical Imaging pipeline card: 22 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.